Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

MISABRI PR 165 mg prolonged-release tablets

Active Ingredient:
pregabalin
Company:  
CNX Therapeutics Ltd (formerly Sunovion Pharmaceuticals Europe) See contact details
ATC code: 
N02BF02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 03 Jan 2025
{pdf} View or print the patient leaflet as PDF
CNX Therapeutics Ltd (formerly Sunovion Pharmaceuticals Europe)
Company image
Address
3rd Floor, LABS House, 15-19 Bloomsbury Way, London, WC1A 2TH, UK
Telephone
+44 (0)207 821 2840
Medical Information Direct Line
+ 44 (0)207 821 2840
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)207 821 2840
WWW
www.cnx-therapeutics.com